FENTANYL AND METABOLITE
General Information
HLAB/HOL Code: FENTA
UPHSM LIS Test #: 021997
Schedule:
Testing Time: 3-6 Days
Testing Lab: Labcorp
UPHSM LIS Test #: 021997
Schedule:
Testing Time: 3-6 Days
Testing Lab: Labcorp
Specimen Info
Only 1 specimen type required, unless otherwise specified
Volume: 0.25 mL
Temperature: Refrigerated
Tube Type: Serum, plasma, or whole blood
Collection Info:
Minimum Volume: 0.05 mL
Container: Red-top tube, lavender-top (EDTA) tube, or green-top (heparin) tube. Do not use a gel-barrier tube. The use of gel-barrier tubes is not recommended due to slow absorption of the drug by the gel. Depending on the specimen volume and storage time, the decrease in drug level due to absorption may be clinically significant.
Collection: Separate serum or plasma within two hours of collection and transfer to a plastic transport tube.
Temperature: Refrigerated
Tube Type: Serum, plasma, or whole blood
Collection Info:
Minimum Volume: 0.05 mL
Container: Red-top tube, lavender-top (EDTA) tube, or green-top (heparin) tube. Do not use a gel-barrier tube. The use of gel-barrier tubes is not recommended due to slow absorption of the drug by the gel. Depending on the specimen volume and storage time, the decrease in drug level due to absorption may be clinically significant.
Collection: Separate serum or plasma within two hours of collection and transfer to a plastic transport tube.
Specimen Acceptability
Cause for Rejection:
Gel-barrier tube
Gel-barrier tube
Methods
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Clinical Utilities
Relief of pain adjunct to general or regional anesthesia moderate to moderately-severe pain. Indications for monitoring include the following: to confirm or identify suspected drug toxicity in chronic use, therapeutic misadventure, or accidental or intentional acute overdose; to aid in the identification of an unknown drug ingested in unknown quantities, drug identification and/or quantitation may be performed as an adjunct for patient management; to monitor selected patient groups at greater risk for analgesic drug toxicity or drug-to-drug interaction; to confirm complete drug absorption and adequate drug elimination as an adjunct to overdose management.
CPT Codes
80299
* The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding
is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
